This list includes 49 medications that start with I, ranging from “Ibandronate” to “Ixekizumab.” These drugs include osteoporosis treatments, antibiotics, biologics and immune-modulating medicines commonly used for bone, infection and autoimmune care.
Medications that start with I are generic drug names beginning with the letter I that span many therapeutic areas. A notable example is ibuprofen, an over-the-counter pain reliever recognized worldwide since the 1960s.
Below you’ll find the table with Generic name, Brand name(s), Drug class, Common uses, and Common side effects.
Generic name: The official chemical name used worldwide; use it to search reliably and compare drugs without brand confusion.
Brand name(s): Familiar trade names show how a drug appears in pharmacies and packaging, helping you recognize marketed versions quickly.
Drug class: Indicates the therapeutic category, so you understand related drugs and how they generally act or are prescribed.
Common uses: Short description of typical conditions treated, which helps you spot why a medicine might be considered.
Common side effects: Lists frequent adverse effects so you can watch for symptoms and discuss tolerability with a care provider.
Last updated: September 28, 2025
Medical disclaimer: This information is for general informational purposes and does not replace professional medical advice.
Medications that start with I
Name | Brand names | Drug class | Typical adult dose (common units) |
---|---|---|---|
Ibandronate | Boniva | Bisphosphonate | 150 mg oral once monthly |
Ibrutinib | Imbruvica | Kinase inhibitor (BTK inhibitor) | 420 mg oral daily |
Ibuprofen | Advil, Motrin, Nurofen | Nonsteroidal anti-inflammatory drug (NSAID) | 200–400 mg oral every 4–6 hours |
Ibutilide | Corvert | Class III antiarrhythmic agent | 1 mg IV infusion over 10 minutes |
Icatibant | Firazyr | Bradykinin B2 receptor antagonist | 30 mg subcutaneous injection as needed |
Icosapent ethyl | Vascepa | Lipid-regulating agent (omega-3 fatty acid) | 2 g oral twice daily with food |
Idarubicin | Idamycin PFS | Anthracycline chemotherapy | Varies; e.g., 12 mg/m² IV daily for 3 days |
Idarucizumab | Praxbind | Antidote, monoclonal antibody | 5 g IV as two separate infusions |
Idelalisib | Zydelig | Kinase inhibitor (PI3K inhibitor) | 150 mg oral twice daily |
Ifosfamide | Ifex | Alkylating agent chemotherapy | Varies; e.g., 1.2 g/m² IV daily for 5 days |
Iloperidone | Fanapt | Atypical antipsychotic | 12–24 mg total oral daily, divided |
Iloprost | Ventavis, Aurlumyn | Prostaglandin vasodilator | Inhaled 6 to 9 times daily |
Imatinib | Gleevec | Tyrosine kinase inhibitor | 400 mg or 600 mg oral daily |
Imiglucerase | Cerezyme | Enzyme replacement therapy | Varies by weight; IV infusion every 2 weeks |
Imipenem | Primaxin | Carbapenem antibiotic | 500 mg IV every 6 hours |
Imipramine | Tofranil | Tricyclic antidepressant (TCA) | 75–150 mg oral daily |
Imiquimod | Aldara, Zyclara | Immune response modifier | Apply 3–5 times per week to affected area |
Indacaterol | Arcapta Neohaler | Long-acting beta-agonist (LABA) | 75 mcg inhaled once daily |
Indapamide | Lozol | Thiazide-like diuretic | 1.25–2.5 mg oral daily |
Indinavir | Crixivan | Protease inhibitor antiviral | 800 mg oral every 8 hours |
Indomethacin | Indocin, Tivorbex | Nonsteroidal anti-inflammatory drug (NSAID) | 25–50 mg oral 2–3 times daily |
Infigratinib | Truseltiq | Kinase inhibitor (FGFR inhibitor) | 125 mg oral daily for 21 days of 28-day cycle |
Infliximab | Remicade, Inflectra, Renflexis | TNF-alpha inhibitor, biologic agent | Varies; e.g., 5 mg/kg IV infusion every 8 weeks |
Inotuzumab ozogamicin | Besponsa | Antibody-drug conjugate | Varies; IV infusion on a cyclical schedule |
Interferon alfa-2b | Intron A | Immunomodulator, biologic | Varies widely by indication |
Interferon beta-1a | Avonex, Rebif | Immunomodulator, biologic | Varies; e.g., 30 mcg IM once weekly |
Iodixanol | Visipaque | Iodinated contrast medium | Varies by procedure; given IV or intra-arterially |
Ipratropium | Atrovent HFA | Anticholinergic bronchodilator | 2 inhalations from MDI four times daily |
Irbesartan | Avapro | Angiotensin II receptor blocker (ARB) | 150–300 mg oral daily |
Irinotecan | Camptosar | Topoisomerase I inhibitor chemotherapy | Varies; e.g., 125 mg/m² IV weekly |
Iron Sucrose | Venofer | Iron replacement product | 100–200 mg IV infusion |
Isavuconazonium | Cresemba | Azole antifungal | 372 mg oral/IV every 8 hours for 6 doses, then daily |
Isocarboxazid | Marplan | Monoamine oxidase inhibitor (MAOI) | 20–60 mg total oral daily, divided |
Isoflurane | Forane | Inhaled general anesthetic | Inhaled concentration of 1–2.5% for maintenance |
Isoniazid | Nydrazid | Antitubercular antibiotic | 300 mg oral daily |
Isoproterenol | Isuprel | Beta-adrenergic agonist | Varies; e.g., 2–10 mcg/min IV infusion |
Isosorbide Dinitrate | Isordil | Nitrate vasodilator | 5–40 mg oral 2–3 times daily |
Isosorbide Mononitrate | Imdur, Monoket | Nitrate vasodilator | 30–120 mg oral once daily (extended-release) |
Isotretinoin | Accutane, Absorica, Claravis | Retinoid | 0.5–1 mg/kg/day oral, divided in 2 doses |
Isradipine | DynaCirc CR | Calcium channel blocker | 2.5–10 mg oral daily |
Istradefylline | Nourianz | Adenosine A2A receptor antagonist | 20–40 mg oral once daily |
Itraconazole | Sporanox, Onmel | Azole antifungal | 200 mg oral once or twice daily |
Ivabradine | Corlanor | HCN channel blocker | 5 mg oral twice daily |
Ivacaftor | Kalydeco | CFTR potentiator | 150 mg oral every 12 hours with fatty food |
Ivermectin | Stromectol, Sklice | Anthelmintic, antiparasitic | Dose by weight; e.g., 12 mg oral single dose |
Ivosidenib | Tibsovo | IDH1 inhibitor | 500 mg oral once daily |
Ixabepilone | Ixempra | Epothilone chemotherapy | 40 mg/m² IV infusion every 3 weeks |
Ixazomib | Ninlaro | Proteasome inhibitor | 4 mg oral once weekly for 3 of 4 weeks |
Ixekizumab | Taltz | Interleukin-17A antagonist, biologic | 80 mg subcutaneous injection every 4 weeks |